Cardio,Cardiovascular News,Cardiologists,Medicines,Heart Health,EKG

* Internet Search Results

*** Search Filter: "RhodeIsland"

Bipasa Sadhukhan - LinkedIn India
Passionate about leveraging technology-driven solutions to enhance efficiency, compliance, and business growth. · Experience: Oracle · Education: Institute of Chartered Accountants of India ·...

2 "Bipasa Sadhukhan" profiles | LinkedIn
View the profiles of professionals named "Bipasa Sadhukhan" on LinkedIn.

7 "Bipasha Sadhukhan" profiles | LinkedIn
View the profiles of professionals named "Bipasha Sadhukhan" on LinkedIn.

Bipasa Sadhukhan posted on LinkedIn
Bipasa Sadhukhan posted images on LinkedIn SAP Project Manager S/4 HANA I SAP EAM/PM Global Certified solution Architect I SAP-Technology Consulting at PWC l SAP Implementation | Digital ...

It’s been a while since I started my role at Rapid E-Suite - LinkedIn
It’s been a while since I started my role at Rapid E-Suite - A Leading Oracle Partner as a Senior Consultant, but I wanted to share this update with everyone.

View my verified achievement from SAP SE. | Bipasa Sadhukhan - LinkedIn
View my verified achievement from SAP SE. SAP Certified Application Associate - SAP S/4HANA for Management Accounting Associates (SAP S/4HANA 2020) was issued by SAP SE to BIPASA SADHUKHAN.

Bipasa Sadhukhan on LinkedIn: View my verified achievement from SAP SE ...
SAP Certified Application Associate - SAP S/4HANA for Financial Accounting Associates (SAP S/4HANA 2020) was issued by SAP SE to BIPASA SADHUKHAN. 34 12 Comments

Bipasha Sadhukhan - LinkedIn India
Computer Science graduate passionate about turning raw data into decisions that matter. I bring hands-on experience in data analysis, baseline research, and evidence-based policy recommendations,...

Bipasa Sadhukhan posted on LinkedIn
Bipasa Sadhukhan ERP Consultant 3y Karthik Srinivasan Karthik Srinivasan is an Influencer

900+ "Bipasa ..............." profiles | LinkedIn
View the profiles of professionals named "Bipasa ..............." on LinkedIn. There are 900+ professionals named "Bipasa ...............", who use LinkedIn to exchange information, ideas,...

* Latest OCD 101 News

*** News Filter: "RhodeIsland"

Sister Marian Steffens O.C.D. Obituary May 16, 2026  O'Neill Funeral Homes
Go Teal for OCD Awareness Week  Rhode Island Monthly
Study expands access to childhood anxiety treatment in Newport County  Newport Daily News
Care New England introduces Butler Behavioral Health. What it means.  The Providence Journal
Are the Kids Alright in Rhode Island?  Rhode Island Monthly
Brown researchers focus on expanding access to pediatric OCD treatment they helped pioneer  Brown University
Newport Mental Health helping children take back lives from anxiety  Newport Daily News
Living a Horror Movie: Navigating Misconceptions About Postpartum OCD  Postpartum Support International
Bradley Hospital enrolling teens with OCD for brain stimulation research study  RINewsToday
MARIO DELLA GROTTA Obituary Jan 5, 2009  Nardolillo Funeral Home
Brain Signals Associated With OCD Discovered by Scientists For First Time  ScienceAlert
'I was horrified': Maine child diagnosed with disorder linked to ticks  KRCR
Breaking a vicious circle  Worcester Telegram
A radical treatment for obsessive-compulsive disorder patients  The Guardian
Bradley Hospital holds 'reunion' for intensive OCD program kids, families, clinicians  The Providence Journal

Common Cardiovascular Symptoms & Warning Signs

Chest Pain or Pressure (Angina) — Sensation of squeezing, fullness, or tightness in the center of the chest that may radiate to the jaw, neck, back, or arm.
Shortness of Breath (Dyspnea) — Difficulty breathing or feeling winded during routine activities, exertion, or while lying flat in bed.
Palpitations or Irregular Heartbeat — Sensations of a racing, fluttering, pounding, or skipping heart rate.
Unexplained Dizziness or Lightheadedness — Sudden feelings of faintness, loss of balance, or near-syncope linked to decreased blood flow to the brain.
Swelling in the Extremities (Edema) — Fluid retention causing notable swelling in the legs, ankles, feet, or abdomen.
Unusual Fatigue and Weakness — Persistent tiredness or exhaustion during simple daily tasks, often an early warning sign of heart failure.
Cold Sweats or Diaphoresis — Sudden onset of unexplained profuse sweating accompanied by chest discomfort or anxiety.
Cyanosis or Pale Skin Tone — A bluish or abnormally pale discoloration of the skin, lips, or nail beds due to poor oxygen circulation.
Persistent Coughing or Wheezing — Chronic cough producing white or pink blood-tinged mucus caused by fluid accumulation in the lungs.
Pain in the Extremities (Claudication) — Cramping or aching in the calves, thighs, or hips during walking, indicating peripheral artery disease.

Current Cardiovascular Treatments

Dual GIP/GLP-1 Receptor Agonists — Advanced metabolic agents like tirzepatide cut major adverse cardiovascular events, reduce systemic vascular inflammation, and improve heart failure outcomes.
Pulsed-Field Ablation (PFA) — Non-thermal electroporation therapy replacing traditional radiofrequency ablation to treat atrial fibrillation with greater tissue selectivity and safety.
SGLT2 Inhibitor Therapy — Guideline-directed medical treatment (e.g., dapagliflozin, empagliflozin) initiated early to reduce hospitalizations and mortality across heart failure spectrums.
Targeted siRNA & Lipid Gene Therapy — Small interfering RNA injectables (like inclisiran) and gene-editing therapies (VERVE-102) providing long-term LDL-C reduction with single-dose schedules.
Transcatheter Valve Therapies (TAVR / TMVR) — Minimally invasive catheter interventions for replacing or repairing severe aortic, mitral, and tricuspid valve stenosis/regurgitation without open-heart surgery.
Aldosterone Synthase Inhibitors — Targeted hormonal pathway medications, such as baxdrostat, designed to treat treatment-resistant hypertension by lowering aldosterone production.
Left Bundle Branch Area Pacing (LBBAP) — Conduction system pacing delivering direct physiological resynchronization as a superior alternative to traditional cardiac resynchronization therapy.
Dual Endothelin Receptor Antagonists — Novel oral therapies like aprocitentan used in combination regimes to target resistant high blood pressure through specialized vascular pathways.
Targeted Anti-Inflammatory Agents — Low-dose colchicine and specialized anti-inflammatory protocols aimed directly at preventing plaque rupture and reducing residual cardiovascular risk.
Mechanical Decompression Systems — Endovascular venous balloon technology and advanced left ventricular assist devices designed to acutely unload intracardiac pressures during heart failure crises.

Key Milestones in Cardiovascular History

Discovery of Blood Circulation (1628) — William Harvey published De Motu Cordis, demonstrating for the first time that blood circulates continuously through the body pumped by the heart.
Invention of the Stethoscope (1816) — René Laennec invented the wooden stethoscope, allowing physicians to auscultate and diagnose internal cardiac sounds non-invasively.
First Human Electrocardiogram (1902) — Willem Einthoven developed the string galvanometer to record the electrical activity of the heart, inventing the modern ECG.
First Human Cardiac Catheterization (1929) — Werner Forssmann performed the first successful cardiac catheterization on himself, opening the path for modern interventional cardiology.
Launch of the Framingham Heart Study (1948) — A landmark long-term epidemiological study began, establishing major risk factors like high blood pressure, cholesterol, and smoking.
Development of the Cardiopulmonary Bypass (1953) — John Gibbon successfully used a heart-lung machine on a human patient, enabling modern open-heart surgery.
First Successful Human Heart Transplant (1967) — Dr. Christiaan Barnard performed the world's first human-to-human heart transplant in Cape Town, South Africa.
First Coronary Angioplasty (1977) — Andreas Grüntzig performed the first successful percutaneous transluminal coronary angioplasty (PTCA) to open blocked arteries.
Introduction of Coronary Stents (1986) — Ulrich Sigwart and Jacques Puel implanted the first coronary stent in a human heart to prevent artery restenosis.
First TAVR Procedure (2002) — Alain Cribier performed the first Transcatheter Aortic Valve Replacement, revolutionizing treatment for aortic stenosis without open-heart surgery.

Current Cardiovascular Research & Breakthroughs

Gene-Editing for Lipid Lowering — Advanced base-editing and RNA therapies (such as VERVE-102) show potential for permanently reducing LDL cholesterol with single-dose targeted gene inactivation.
AI-Driven Predictive Diagnostics — Deep learning algorithms now evaluate polygenic risk scores and real-time imaging data to predict cardiac events years before clinical symptoms appear.
Stem Cell Remuscularization — Regenerative cardiac cell therapies using stem-cell-derived cardiomyocytes aim to repair post-infarct scar tissue and restore contractile function.
Pulsed-Field Ablation (PFA) — Non-thermal electroporation technology is transforming arrhythmia management by selectively isolating cardiac tissue with lower procedural risk.
Anti-Inflammatory Therapies — Target-specific anti-inflammatory drugs are being validated to reduce residual vascular risk and suppress ongoing atheroma plaque progression.
Transcatheter Valve Evolution (TMVR/TAVR) — Next-generation transcatheter systems are expanding treatment options for complex structural valve conditions without traditional open surgery.
Digital Twin Hemodynamic Modeling — Virtual patient-specific cardiac models integrate imaging and biomarkers to simulate interventional outcomes before execution.
Conduction System Pacing (LBBAP) — Left bundle branch area pacing is replacing traditional biventricular pacing to provide more natural physiological resynchronization.
Cardioprotective Metabolic Drugs — Broadening applications of SGLT2 inhibitors and GLP-1 receptor agonists demonstrate significant reductions in heart failure admissions and vascular events.
Novel Aldosterone Synthase Inhibitors — New drug classes like Baxdrostat provide target-specific control for resistant hypertension by directly modulating hormone pathways.